CLINICAL_TRIALS trial_result · 2021-12-29

Clinical Trial Update: Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001) [Phase 1]

Phase 1 dose-ranging trial assessing safety and immunogenicity of V590 COVID-19 vaccine in healthy adults; terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Coronavirus Disease (COVID-19) | Phase 1 | Status: TERMINATED | Results posted: 2021-12-29